Literature DB >> 2410382

Peripheral retinal neovascularization in diabetes mellitus.

W M Grabowski, G C Brown, A Cruess.   

Abstract

The cases of seven patients with diabetes mellitus and peripheral proliferative retinopathy (retinal neovascularization at or anterior to the equator) were studied. Associated abnormalities found included systemic arterial hypertension in five, a positive fluorescent treponemal antibody titer in four, and benign monoclonal gammopathy, intravenous drug abuse and hemoglobin AS each in one patient. The presence of additional systemic diseases should be suspected in diabetic patients with predominantly peripheral proliferative retinopathy.

Entities:  

Mesh:

Year:  1985        PMID: 2410382     DOI: 10.1007/bf00136461

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  5 in total

1.  Midperipheral fundus involvement in diabetic retinopathy.

Authors:  K Shimizu; Y Kobayashi; K Muraoka
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

2.  Secondary syphilitic uveitis.

Authors:  M W Belin; A L Baltch; P B Hay
Journal:  Am J Ophthalmol       Date:  1981-08       Impact factor: 5.258

3.  Disk and peripheral retinal neovascularization secondary to talc and cornstarch emboli.

Authors:  A J Brucker
Journal:  Am J Ophthalmol       Date:  1979-11       Impact factor: 5.258

Review 4.  Peripheral proliferative retinopathies.

Authors:  L M Jampol; M H Goldbaum
Journal:  Surv Ophthalmol       Date:  1980 Jul-Aug       Impact factor: 6.048

5.  Proliferative retinopathy in sickle cell trait. Report of seven cases.

Authors:  K C Nagpal; G K Asdourian; D Patrianakos; M F Goldberg; M F Rabb; M Goldbaum; M Raichand
Journal:  Arch Intern Med       Date:  1977-03
  5 in total
  2 in total

1.  Peripheral proliferative retinopathies.

Authors:  G C Brown; R H Brown; M M Brown
Journal:  Int Ophthalmol       Date:  1987-10       Impact factor: 2.031

2.  Classification of proliferative diabetic retinopathy.

Authors:  F Cardillo Piccolino; M Zingirian; C Mosci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.